Study of Weekly Paclitaxel and Cisplatin in FIGO IB2 and IIA2 Cervical Cancer Followed by Radical Hysterectomy

NCT02432365 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

64

Enrollment

OTHER

Sponsor class

Conditions

Cervical Cancer

Interventions

DRUG: paclitaxel
DRUG: cisplatin
PROCEDURE: Radical hysterectomy and bilateral pelvic lymphadenectomy

Sponsor

Chang Gung Memorial Hospital

Collaborators

[object Object]
[object Object]